Copyright Reports & Markets. All rights reserved.

Global Pseudorabies Virus Vaccine Market Opportunities and Forecast 2022-2028

Request for Sample of this report
Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Pseudorabies Virus Vaccine Market Status and Forecast (2017-2028)
      • 1.3.2 Global Pseudorabies Virus Vaccine Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Pseudorabies Virus Vaccine Supply by Company

    • 2.1 Global Pseudorabies Virus Vaccine Sales Volume by Company
    • 2.2 Global Pseudorabies Virus Vaccine Sales Value by Company
    • 2.3 Global Pseudorabies Virus Vaccine Price by Company
    • 2.4 Pseudorabies Virus Vaccine Production Location and Sales Area of Main Manufacturers
    • 2.5 Trend of Concentration Rate

    3 Global and Regional Pseudorabies Virus Vaccine Market Status by Type

    • 3.1 Pseudorabies Virus Vaccine Type Introduction
      • 3.1.1 Inactivated Vaccine
      • 3.1.2 Naturally Deficient Attenuated Vaccine
      • 3.1.3 Genetic Engineering Vaccine
    • 3.2 Global Pseudorabies Virus Vaccine Market by Type
      • 3.2.1 Global Pseudorabies Virus Vaccine Sales Volume by Type (2017-2022)
      • 3.2.2 Global Pseudorabies Virus Vaccine Sales Value by Type (2017-2022)
      • 3.2.3 Global Pseudorabies Virus Vaccine Price by Type (2017-2022)
    • 3.3 North America: by Type
    • 3.4 Europe: by Type
    • 3.5 Asia Pacific: by Type
    • 3.6 Central & South America: by Type
    • 3.7 Middle East & Africa: by Type

    4 Global and Regional Pseudorabies Virus Vaccine Market Status by Application

    • 4.1 Pseudorabies Virus Vaccine Segment by Application
      • 4.1.1 Government Tender
      • 4.1.2 Market Sales
    • 4.2 Global Pseudorabies Virus Vaccine Market by Application
      • 4.2.1 Global Pseudorabies Virus Vaccine Sales Volume by Application (2017-2022)
      • 4.2.2 Global Pseudorabies Virus Vaccine Sales Value by Application (2017-2022)
      • 4.2.3 Global Pseudorabies Virus Vaccine Price by Application (2017-2022)
    • 4.3 North America: by Application
    • 4.4 Europe: by Application
    • 4.5 Asia Pacific: by Application
    • 4.6 Central & South America: by Application
    • 4.7 Middle East & Africa: by Application

    5 Global Pseudorabies Virus Vaccine Market Status by Region

    • 5.1 Global Pseudorabies Virus Vaccine Market by Region
      • 5.1.1 Global Pseudorabies Virus Vaccine Sales Volume by Region
      • 5.1.2 Global Pseudorabies Virus Vaccine Sales Value by Region
    • 5.2 North America Pseudorabies Virus Vaccine Market Status
    • 5.3 Europe Pseudorabies Virus Vaccine Market Status
    • 5.4 Asia Pacific Pseudorabies Virus Vaccine Market Status
    • 5.5 Central & South America Pseudorabies Virus Vaccine Market Status
    • 5.6 Middle East & Africa Pseudorabies Virus Vaccine Market Status

    6 North America Pseudorabies Virus Vaccine Market Status

    • 6.1 North America Pseudorabies Virus Vaccine Market by Country
      • 6.1.1 North America Pseudorabies Virus Vaccine Sales Volume by Country (2017-2022)
      • 6.1.2 North America Pseudorabies Virus Vaccine Sales Value by Country (2017-2022)
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Pseudorabies Virus Vaccine Market Status

    • 7.1 Europe Pseudorabies Virus Vaccine Market by Country
      • 7.1.1 Europe Pseudorabies Virus Vaccine Sales Volume by Country (2017-2022)
      • 7.1.2 Europe Pseudorabies Virus Vaccine Sales Value by Country (2017-2022)
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Pseudorabies Virus Vaccine Market Status

    • 8.1 Asia Pacific Pseudorabies Virus Vaccine Market by Country
      • 8.1.1 Asia Pacific Pseudorabies Virus Vaccine Sales Volume by Country (2017-2022)
      • 8.1.2 Asia Pacific Pseudorabies Virus Vaccine Sales Value by Country (2017-2022)
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Pseudorabies Virus Vaccine Market Status

    • 9.1 Central & South America Pseudorabies Virus Vaccine Market by Country
      • 9.1.1 Central & South America Pseudorabies Virus Vaccine Sales Volume by Country (2017-2022)
      • 9.1.2 Central & South America Pseudorabies Virus Vaccine Sales Value by Country (2017-2022)
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Pseudorabies Virus Vaccine Market Status

    • 10.1 Middle East & Africa Pseudorabies Virus Vaccine Market by Country
      • 10.1.1 Middle East & Africa Pseudorabies Virus Vaccine Sales Volume by Country (2017-2022)
      • 10.1.2 Middle East & Africa Pseudorabies Virus Vaccine Sales Value by Country (2017-2022)
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Supply Chain and Manufacturing Cost Analysis

    • 11.1 Supply Chain Analysis
    • 11.2 Production Process Chart Analysis
    • 11.3 Raw Materials and Key Suppliers Analysis
      • 11.3.1 Raw Materials Introduction
      • 11.3.2 Raw Materials Key Suppliers List
    • 11.4 Pseudorabies Virus Vaccine Manufacturing Cost Analysis
    • 11.5 Pseudorabies Virus Vaccine Sales Channel and Distributors Analysis
      • 11.5.1 Pseudorabies Virus Vaccine Sales Channel
      • 11.5.2 Pseudorabies Virus Vaccine Distributors
    • 11.6 Pseudorabies Virus Vaccine Downstream Major Buyers

    12 Global Pseudorabies Virus Vaccine Market Forecast by Type and by Application

    • 12.1 Global Pseudorabies Virus Vaccine Sales Volume and Sales Value Forecast (2023-2028)
    • 12.2 Global Pseudorabies Virus Vaccine Forecast by Type
      • 12.2.1 Global Pseudorabies Virus Vaccine Sales Volume Forecast by Type
      • 12.2.2 Global Pseudorabies Virus Vaccine Sales Value Forecast by Type
      • 12.2.3 Global Pseudorabies Virus Vaccine Price Forecast by Type
    • 12.3 Global Pseudorabies Virus Vaccine Forecast by Application
      • 12.3.1 Global Pseudorabies Virus Vaccine Sales Volume Forecast by Application
      • 12.3.2 Global Pseudorabies Virus Vaccine Sales Value Forecast by Application
      • 12.3.3 Global Pseudorabies Virus Vaccine Price Forecast by Application

    13 Global Pseudorabies Virus Vaccine Market Forecast by Region/Country

    • 13.1 Global Pseudorabies Virus Vaccine Market Forecast by Region (2023-2028)
      • 13.1.1 Global Pseudorabies Virus Vaccine Sales Volume Forecast by Region (2023-2028)
      • 13.1.2 Global Pseudorabies Virus Vaccine Sales Value Forecast by Region (2023-2028)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 Zoetis
      • 14.1.1 Company Information
      • 14.1.2 Pseudorabies Virus Vaccine Product Introduction
      • 14.1.3 Zoetis Pseudorabies Virus Vaccine Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.1.4 SWOT Analysis
    • 14.2 Yunnan Biopharmaceutical Co.
      • 14.2.1 Company Information
      • 14.2.2 Pseudorabies Virus Vaccine Product Introduction
      • 14.2.3 Yunnan Biopharmaceutical Co. Pseudorabies Virus Vaccine Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.2.4 SWOT Analysis
    • 14.3 Wuhan Keqian Biological Co., Ltd.
      • 14.3.1 Company Information
      • 14.3.2 Pseudorabies Virus Vaccine Product Introduction
      • 14.3.3 Wuhan Keqian Biological Co., Ltd. Pseudorabies Virus Vaccine Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.3.4 SWOT Analysis
    • 14.4 Tianbang
      • 14.4.1 Company Information
      • 14.4.2 Pseudorabies Virus Vaccine Product Introduction
      • 14.4.3 Tianbang Pseudorabies Virus Vaccine Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.4.4 SWOT Analysis
    • 14.5 Sichuan Huashen
      • 14.5.1 Company Information
      • 14.5.2 Pseudorabies Virus Vaccine Product Introduction
      • 14.5.3 Sichuan Huashen Pseudorabies Virus Vaccine Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.5.4 SWOT Analysis
    • 14.6 Sichuan Hailinge Biological Pharmaceutical Co., Ltd.
      • 14.6.1 Company Information
      • 14.6.2 Pseudorabies Virus Vaccine Product Introduction
      • 14.6.3 Sichuan Hailinge Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.6.4 SWOT Analysis
    • 14.7 Shanxi Longkel Bio-Pharmaceutical Co., Ltd.
      • 14.7.1 Company Information
      • 14.7.2 Pseudorabies Virus Vaccine Product Introduction
      • 14.7.3 Shanxi Longkel Bio-Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.7.4 SWOT Analysis
    • 14.8 Shanghui Huahong Biological Engineering Co., Ltd.
      • 14.8.1 Company Information
      • 14.8.2 Pseudorabies Virus Vaccine Product Introduction
      • 14.8.3 Shanghui Huahong Biological Engineering Co., Ltd. Pseudorabies Virus Vaccine Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.8.4 SWOT Analysis
    • 14.9 Qilu Animal Health Products Co., Ltd.
      • 14.9.1 Company Information
      • 14.9.2 Pseudorabies Virus Vaccine Product Introduction
      • 14.9.3 Qilu Animal Health Products Co., Ltd. Pseudorabies Virus Vaccine Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.9.4 SWOT Analysis
    • 14.10 Preh Bio
      • 14.10.1 Company Information
      • 14.10.2 Pseudorabies Virus Vaccine Product Introduction
      • 14.10.3 Preh Bio Pseudorabies Virus Vaccine Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.10.4 SWOT Analysis
    • 14.11 Merial Limited
    • 14.12 Merck
    • 14.13 Liaoning Yikang Biological Co., Ltd.
    • 14.14 Jiujiang Bomeilai Biological Pharmaceutical Co., Ltd.
    • 14.15 Jilin Zhengye Bioengineering Group
    • 14.16 Jilin Heyuan Biological Engineering Co., Ltd.
    • 14.17 Jiangsu Nannong High-Tech Co.
    • 14.18 Huapai Biological Engineering Group Co., Ltd.
    • 14.19 Hipra
    • 14.20 Harvey
    • 14.21 Haley
    • 14.22 Guangxi Liyuan Biological Co., Ltd.
    • 14.23 Guangdong Yongshun Biological Pharmaceutical Co., Ltd.
    • 14.24 Dabei Nong
    • 14.25 China Biotechnology Co., Ltd.
    • 14.26 CHINA ANIMAL HUSBANDRY INDUSTRY
    • 14.27 Boehringer Ingelheim Animal Health (USA) Co., Ltd.
    • 14.28 Beijing Xinde Weite Technology Co., Ltd.
    • 14.29 Beijing Veterinary Biopharmaceutical Factory
    • 14.30 Anhui Divinity Biological Products

    15 Conclusion

      16 Methodology

      This report provides a comprehensive analysis of current global Pseudorabies Virus Vaccine market based on segmented types and downstream applications. Major product development trends are discussed under major downstream segment scenario. This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the Pseudorabies Virus Vaccine industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies.

      According to this survey, the global Pseudorabies Virus Vaccine market is estimated at $ million in 2021, and projected to grow at a CAGR of % to $ million by 2028.

      Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global Pseudorabies Virus Vaccine Market Opportunties and Forecast 2022-2028 report makes a brilliant attempt to unveil key opportunities available in the global Pseudorabies Virus Vaccine market under the covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information.

      The Global Pseudorabies Virus Vaccine Market has been exhibited in detail in the following chapters
      Chapter 1 displays the basic product introduction and market overview.
      Chapter 2 provides the competition landscape of global Pseudorabies Virus Vaccine industry.
      Chapter 3 provides the market analysis by type and by region
      Chapter 4 provides the market analysis by application and by region
      Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis.
      Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis.
      Chapter 12 provides the market forecast by type and by application
      Chapter 13 provides the market forecast by region
      Chapter 14 profiles global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis.
      Chapter 15 conclusions

      Segmented by Type
      Inactivated Vaccine
      Naturally Deficient Attenuated Vaccine

      Segmented by Application
      Government Tender
      Market Sales

      Segmented by Country
      North America
      United States
      Canada
      Mexico
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Asia Pacific
      China
      Japan
      Korea
      Southeast Asia
      India
      Australasia
      Central & South America
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Iran
      Israel
      Turkey
      South Africa
      Saudi Arabia

      Key manufacturers included in this survey
      Wuhan Keqian Biological Co., Ltd.
      Tianbang
      Sichuan Huashen
      Sichuan Hailinge Biological Pharmaceutical Co., Ltd.
      Shanxi Longkel Bio-Pharmaceutical Co., Ltd.
      Shanghui Huahong Biological Engineering Co., Ltd.
      Qilu Animal Health Products Co., Ltd.
      Preh Bio
      Merial Limited
      Merck
      Liaoning Yikang Biological Co., Ltd.
      Jiujiang Bomeilai Biological Pharmaceutical Co., Ltd.
      Jilin Zhengye Bioengineering Group
      Jilin Heyuan Biological Engineering Co., Ltd.
      Jiangsu Nannong High-Tech Co.
      Huapai Biological Engineering Group Co., Ltd.
      Hipra
      Harvey
      Haley
      Guangxi Liyuan Biological Co., Ltd.
      Guangdong Yongshun Biological Pharmaceutical Co., Ltd.
      Dabei Nong
      China Biotechnology Co., Ltd.
      CHINA ANIMAL HUSBANDRY INDUSTRY
      Boehringer Ingelheim Animal Health (USA) Co., Ltd.
      Beijing Xinde Weite Technology Co., Ltd.
      Beijing Veterinary Biopharmaceutical Factory
      Anhui Divinity Biological Products
      Buy now